Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
REPL Replimune Group $13.55 -3.3 (-19.58%) 06:33 11/14/19 11/14 06:33 11/14/19 06:33 Syndicate	Replimune Group 3.678M share Secondary priced at $13.61 » The deal size was reduced… The deal size was reduced to 3.678M shares of common stock from 5M shares of common stock. JPMorgan, SVB Leerink and BMO Capital acted as joint book running managers for the offering. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov
REPL Replimune Group $16.66 -0.47 (-2.74%) 16:22 11/12/19 11/12 16:22 11/12/19 16:22 Syndicate	Replimune Group files to sell 5M shares of common stock » J.P. Morgan Securities… J.P. Morgan Securities LLC, SVB Leerink LLC, and BMO Capital Markets Corp. are acting as book-running managers for the proposed offering. The 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov
REPL Replimune Group $17.24 0.11 (0.64%) 10:25 11/12/19 11/12 10:25 11/12/19 10:25 Conference/Events	Replimune Group participates in a conference call with JPMorgan » SMid Biotech Analyst Rama… SMid Biotech Analyst Rama holds a conference call with CEO Coffin on November 12 at 11 am hosted by JPMorgan. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov
REPL Replimune Group $17.13 0.33 (1.96%) 04:55 11/12/19 11/12 04:55 11/12/19 04:55 Conference/Events	Replimune Group management to meet with Wedbush » Meeting to be held in… Meeting to be held in Boston on November 12 hosted by Wedbush. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov
REPL Replimune Group $17.13 0.33 (1.96%) 04:55 11/12/19 11/12 04:55 11/12/19 04:55 Conference/Events	Replimune Group participates in a conference call with JPMorgan » SMid Biotech Analyst Rama… SMid Biotech Analyst Rama holds a conference call with CEO Coffin on November 12 at 11 am hosted by JPMorgan. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov

MGM MGM Resorts $31.41 0.01 (0.03%) , DSS Document Security $0.34 0.0059 (1.76%) … 13:18 11/11/19 11/11 13:18 11/11/19 13:18 On The Fly	Fly Insider: MGM, IDEXX Laboratories among week's notable insider trades » Welcome to "Fly Insider,"… Open Full Text MGM MGM Resorts $31.41 0.01 (0.03%) DSS Document Security $0.34 0.0059 (1.76%) CNFR Conifer Holdings $4.32 0.42 (10.77%) OFIX Orthofix $44.42 -0.46 (-1.03%) LMNX Luminex $19.33 0.96 (5.23%) UBER Uber $26.93 -0.08 (-0.30%) REPL Replimune Group $16.69 -0.11 (-0.65%) TPX Tempur Sealy $86.40 0.82 (0.96%) IDXX Idexx Laboratories $253.71 -0.8 (-0.31%) BX Blackstone $51.89 0.475 (0.92%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov 12 Nov 19 Nov 21 Nov 04 Dec 09 Dec
REPL Replimune Group $16.76 -0.04 (-0.24%) , REGN Regeneron $339.40 -2.54 (-0.74%) 11:21 11/11/19 11/11 11:21 11/11/19 11:21 Recommendations	Replimune Group, Regeneron analyst commentary at Roth Capital » Replimune Group price… Replimune Group price target raised to $30 from $20 at Roth Capital. Roth Capital analyst Tony Butler increased his price target on Replimune (REPL) shares to $30 from $20 after the company reported Q2 updates and presented data over the weekend at the SITC meeting. Replimune developed a new trial protocol in solid organ transplant patients with CSCC and in melanoma patients who are refractory to prior treatment with anti-PD-1 directed therapy, while it also has initiated a registrational phase 2 trial of RP1 in combination with Regeneron's (REGN) anti-PD-1 antibody cemiplimab versus cemiplimab alone, noted Butler, who keeps a Buy rating on Replimune shares. REPL Replimune Group $16.76 -0.04 (-0.24%) REGN Regeneron $339.40 -2.54 (-0.74%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov 07 Dec
REPL Replimune Group $16.80 0.02 (0.12%) 09:21 11/11/19 11/11 09:21 11/11/19 09:21 Conference/Events	Replimune Group management to meet with Wedbush » Meeting to be held in… Meeting to be held in Boston on November 12 hosted by Wedbush. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov
REPL Replimune Group $16.80 0.02 (0.12%) 08:49 11/11/19 11/11 08:49 11/11/19 08:49 Hot Stocks	Replimune Group says manufacturing build-out remains on schedule » The 63,000-square-foot… The 63,000-square-foot facility in Framingham, MA is intended to provide multi-product manufacturing capabilities for Replimune's Immulytic product candidates. The capacity of this facility will be sufficient to support full commercialization of the Company's product candidates. An occupancy certificate for the facility has been obtained and technology transfer is underway. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov
REPL Replimune Group $16.80 0.02 (0.12%) 08:48 11/11/19 11/11 08:48 11/11/19 08:48 Hot Stocks	Breaking Hot Stocks news story on Replimune Group » Replimune says Phase 1… Replimune says Phase 1 clinical trial of RP3 'on track' to initiate in 2020 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Nov 12 Nov

On The Fly

News and insights, exclusive to thefly.com

15:08	On The Fly: Weekly technical notes for Russell 2000»
15:07	On The Fly: Weekly technical notes for S&P 500»
14:20	Grifols higher after new data show reduction in Alzheimer's progression»
12:58	On The Fly: ETF fund flow highlights»
10:34	3M higher after Bloomberg says running auction for drug delivery unit»

View all On The Fly Stories »

Upcoming
Events (10)

SPT	Sprout Social - SPT
	105th Scientific Assembly & Annual Meeting
	Asia Internet, Media and Education Conference
	FFANY 2019
JNJ ...	12th Clinical Trials on Alzheimer’s Disease (CTAD) Congress
DSGX	Descartes Systems
MPWR	Monolithic Power
DHR	Danaher
VSLR	First Solar
SPGI	S&P Global

View all of today’s events »

Today’s
Syndicate (7)

DT	Secondary
EVRI	Secondary
GDS	Secondary
PLUG	Secondary
TTEC	Secondary
CATC	Spot Secondary
ISEE	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial